By
Drug Target Review2024-04-30T12:00:33
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-05T13:24:00Z
Sponsored by HUB Organoids
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2023-07-04T10:05:58
Sponsored by Revvity
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-28T11:38:32
Sponsored by Bio-Techne
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
Site powered by Webvision Cloud